Concepedia

Thelma M. Watson

TM

Statistics

Publications

10

Citations

978

H-Index

10

Active since

1984

Affiliations

National Cancer Institute(Current)

Science Applications International Corporation (United States)

Center for Cancer Research

National Institutes of Health

Frederick National Laboratory for Cancer Research

Thelma M. Watson is an author at National Cancer Institute specializing in oncology, cancer immunology, and immunology.

Publications per year

1984–2005

10

Publications

10

Complete molecular remissions induced by patient-specific vaccination plus granulocyte–monocyte colony-stimulating factor against lymphoma

Maurizio Bendandi, Christopher D. Gocke, Carol B. Kobrin et al. · Nature Medicine · 1999 · 592 citations

Medicine, Hematology, Immunology +12

Hepatotoxicity in cancer patients receiving erb-38, a recombinant immunotoxin that targets the erbB2 receptor.

Lee H. Pai-Scherf, J Villa, Deborah A. Pearson et al. · PubMed · 1999 · 108 citations

Pharmacy, Oncology, Toxicology +14

Human Autologous Tumor-Specific T-Cell Responses Induced by Liposomal Delivery of a Lymphoma Antigen

Sattva S. Neelapu, Sivasubramanian Baskar, Barry L. Gause et al. · Clinical Cancer Research · 2004 · 74 citations · Full text

Medicine, Immunology, Oncology +17

Pretreatment with Rituximab Does Not Inhibit the Human Immune Response against the Immunogenic Protein LMB-1

Raffit Hassan, Juanita Williams-Gould, Thelma M. Watson et al. · Clinical Cancer Research · 2004 · 52 citations

Life Sciences, Immunology, Pharmacology +17

Prolonged, continuous treatment of hairy cell leukemia patients with recombinant interferon-alpha 2a.

JW d Smith, DL Longo, W J Urba et al. · PubMed · 1991 · 49 citations

Medicine, Hematology, Oncology +9

1–5 of 10